Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma | NCT00912847 | Trialant
CompletedObservationalUpdated Jun 3, 2009
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
ClinicalTrials.gov ID
NCT00912847
Lead Sponsor
Chinese University of Hong KongOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
1,018Actual
Last Update Posted
Jun 3, 2009Estimated
Start Date
Oct 1997
Primary Completion Date
Apr 2004Actual
Completion Date
Apr 2004Actual
Official Title
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
Brief Summary
The purpose of this study is:
To establish and compare the diagnostic utilities for hepatocellular carcinoma (HCC) screening tests of (a) HS-AFP, (b) AFP + US,(c) AFP alone and (d) US alone (within HBV carriers between age 40 and 70 years);
To establish the cost-effectiveness of the screening tests;
To compare tumor sizes, resection rates, and survival rates up to 18 months between those who were screened by HS-AFP those of a historical control group that was not screened.